Drug intelligence / Profile preview

MEVAC RVF

Development stage
Unknown
Lead developer
Kemin Industries
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

MEVAC RVF is a veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the active immunization of ruminants, including cattle, sheep, and goats, against Rift Valley Fever (RVF). RVF is a significant viral zoonotic disease caused by the Rift Valley fever virus (RVFV), which is transmitted by mosquitoes and can lead to severe clinical disease, high mortality in young animals, and widespread 'abortion storms' in livestock. The vaccine is formulated as an inactivated viral suspension, typically adjuvanted with aluminum hydroxide to enhance the immune response. By using an inactivated platform, MEVAC RVF provides a safe alternative to live-attenuated vaccines, eliminating the risk of viral reversion or accidental transmission to humans while effectively stimulating protective humoral and cellular immunity in the target species.

Brand names
MEVAC RVF
Other names
Rift Valley Fever VaccineRift Valley Fever Vaccine (Ruminants)

Beyond the preview

Go deeper on MEVAC RVF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEVAC RVF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call